TY - JOUR
T1 - The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein
AU - Hegde, Ramesh
AU - Srinivasula, Srinivasa M.
AU - Datta, Pinaki
AU - Madesh, Muniswamy
AU - Wassell, Richard
AU - Zhang, Zhi Jia
AU - Cheong, Na Eun
AU - Nejmeh, Julie
AU - Fernandes-Alnemri, Teresa
AU - Hoshino, Shin Ichi
AU - Alnemri, Emad S.
PY - 2003/10/3
Y1 - 2003/10/3
N2 - Smac/Diablo and HtrA2/Omi are inhibitors of apoptosis (IAP)-binding proteins released from the mitochondria of human cells during apoptosis and regulate apoptosis by liberating caspases from IAP inhibition. Here we describe the identification of a proteolytically processed isoform of the polypeptide chain-releasing factor GSPT1/eRF3 protein, which functions in translation, as a new IAP-binding protein. In common with other IAP-binding proteins, the processed GSPT1 protein harbors a conserved N-terminal IAP-binding motif (AKPF). Additionally, processed GSPT1 interacts biochemically with IAPs and could promote caspase activation, IAP ubiquitination and apoptosis. The IAP-binding motif of the processed GSPT1 is absolutely required for these activities. Our findings are consistent with a model whereby processing of GSPT1 into the IAP-binding isoform could potentiate apoptosis by liberating caspases from IAP inhibition, or target IAPs and the processed GSPT1 for proteasome-mediated degradation.
AB - Smac/Diablo and HtrA2/Omi are inhibitors of apoptosis (IAP)-binding proteins released from the mitochondria of human cells during apoptosis and regulate apoptosis by liberating caspases from IAP inhibition. Here we describe the identification of a proteolytically processed isoform of the polypeptide chain-releasing factor GSPT1/eRF3 protein, which functions in translation, as a new IAP-binding protein. In common with other IAP-binding proteins, the processed GSPT1 protein harbors a conserved N-terminal IAP-binding motif (AKPF). Additionally, processed GSPT1 interacts biochemically with IAPs and could promote caspase activation, IAP ubiquitination and apoptosis. The IAP-binding motif of the processed GSPT1 is absolutely required for these activities. Our findings are consistent with a model whereby processing of GSPT1 into the IAP-binding isoform could potentiate apoptosis by liberating caspases from IAP inhibition, or target IAPs and the processed GSPT1 for proteasome-mediated degradation.
UR - http://www.scopus.com/inward/record.url?scp=0141643236&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141643236&partnerID=8YFLogxK
U2 - 10.1074/jbc.M303179200
DO - 10.1074/jbc.M303179200
M3 - Article
C2 - 12865429
AN - SCOPUS:0141643236
SN - 0021-9258
VL - 278
SP - 38699
EP - 38706
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 40
ER -